National Institute of General Medical Sciences; Notice of Closed Meeting, 106539-106540 [2024-31148]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 249 / Monday, December 30, 2024 / Notices
Review Panel chartered by the HHS, and
assists providers with Malpractice
Claims Review Panel interactions; (14)
submits payment reports to the National
Practitioner Data Bank; (15) maintains
case files and a malpractice claims
database; (16) provides case summaries,
peer review, outcome information, and
feedback of risk management
recommendations; (17) disseminates
information about the review process;
(18) responds to outside organizations
requesting tort claim-involvement
histories on former employees; and (19)
responds to Tort Claims inquiries from
governmental agencies, media, Tribal
and Urban Indian organizations, and
advocacy groups with the Office of
General Council guidance.
ddrumheller on DSK120RN23PROD with NOTICES1
Division of Innovation and
Improvement (GAPC)
(1) Provides trainings on innovative
thinking and performance improvement
techniques; (2) provides training on
empathy and relational intelligence to
better understand colleagues and
stakeholders and maximize teamwork;
(3) integrates innovative thinking into
quality improvement and policy
formation processes to stimulate rapid
idea generation; (4) oversees training
programs to increase quality
improvement capacity and standardize
improvement methodology to test smallscale changes at the local level; (5)
reviews use of health information
technology and data to improve
performance, quality and service; (6)
monitors patient and staff satisfaction
with health care service delivery; (7)
leads change management for practice
transformation to embrace new models
of care delivery and to enhance
efficiency of the care delivery process;
(8) develops programs to promote the
implementation of patient-centered care
models; (9) coordinates sharing of best
practices between Area Quality
Managers and Service Unit Quality
Assurance and Performance
Improvement officers; and (10) supports
and promotes patient-centered care
including Patient and Family
Engagement, and promotes unification
of Area Quality Managers and Service
Unit Quality Assurance and
Performance Improvement Officers.
Division of Compliance (GAPD)
(1) Coordinates the IHS’s compliance
program; (2) administers the agency’s
internal control program in accordance
with the Federal Managers’ Financial
Integrity Act, OMB Circular No. A–123,
GAO Green Book, and other applicable
requirements; (3) oversees and
coordinates the agency’s efforts to
establish and maintain proper internal
VerDate Sep<11>2014
23:58 Dec 27, 2024
Jkt 265001
controls; (4) oversees and
institutionalizes a continuous
compliance review process; (5) manages
goals and objectives for the Compliance
program, integrates them with broader
IHS-wide strategic goals/objectives, and
tracks progress toward achieving them;
(6) evaluates and monitors systems of
internal control across IHS and uses the
assessments of the internal control
program as an integral part of ERM to
effectively manage risks across IHS; (7)
Serves as the IHS liaison office to the
Government Accountability Office
(GAO) and Office of Inspector General
(OIG); (8) coordinates the development,
clearance, and transmittal of IHS
responses and follow-up to reports
issued by the OIG, the GAO, and other
federal internal and external authorities
reviewing risk management and internal
controls; (9) provides leadership and
direction on activities for continuous
improvement of management
accountability and administrative
systems for effective and efficient
program support services IHS-wide; and
(10) oversees and coordinates the
annual development and submission of
the agency’s federal Activities Inventory
Reform Act report to the HHS.
Section GA–30, Indian Health Service—
Delegations of Authority
All delegations of authority and redelegations of authority made to IHS
officials that were in effect immediately
prior to this reorganization, and that are
consistent with this reorganization,
shall continue in effect pending further
re-delegation.
Roselyn Tso,
Director, Indian Health Service.
[FR Doc. 2024–31273 Filed 12–27–24; 8:45 am]
BILLING CODE 4166–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
PO 00000
Frm 00134
Fmt 4703
Sfmt 4703
106539
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; NHP Review.
Date: January 31, 2025.
Time: 10:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute on Aging, 5601
Fishers Lane, Suite 8B, Rockville, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Bita Nakhai, Ph.D.,
Scientific Review Officer, National Institute
on Aging, National Institutes of Health, 5601
Fishers Lane, Suite 8B, Rockville, MD 20852,
(301) 402–7701, nakhaib@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 19, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30880 Filed 12–27–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group Training and Workforce Development
Study Section—C Training & Workforce
Development Study Section C (TWD–C)
Review of applications for the B2B &
IRACDA Programs and Scientific Meetings &
Conferences.
Date: February 20–21, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: Sonia Ivette OrtizMiranda, Ph.D., Scientific Review Officer,
E:\FR\FM\30DEN1.SGM
30DEN1
ddrumheller on DSK120RN23PROD with NOTICES1
106540
Federal Register / Vol. 89, No. 249 / Monday, December 30, 2024 / Notices
Scientific Review Branch, National Institute
of General Medical Sciences, National
Institutes of Health, 45 Center Drive, MSC
6200, Bethesda, Maryland 20892, 301–402–
9448, sonia.ortiz-miranda@nih.gov.
Name of Committee: National Institute of
General Medical Sciences, Initial Review
Group Training and Workforce Development
Study Section—B.
Date: February 24–25, 2025.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: Latarsha J. Carithers,
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN12C,
Bethesda, Maryland 20892, 301–594–4859,
latarsha.carithers@nih.gov.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group Training and Workforce Development
Study Section—A.
Date: March 6–7, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: Adam Lawrence
Heuberger, Ph.D., Scientific Review Officer,
Office of Scientific Review, National Institute
of General Medical Sciences, National
Institutes of Health, 45 Center Drive, MSC
6200, Bethesda, Maryland 20892, 301–480–
4151, adam.heuberger@nih.gov.
Name of Committee: National Institute of
General Medical Sciences, Special Emphasis
Panel; Review of ARC F99 and Mosaic K99
applications.
Date: March 11–12, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: Lee Warren Slice, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN12, Bethesda,
Maryland 20892, 301–435–0807, slicelw@
mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences, Special Emphasis
Panel; Review of Support for Research
Excellence (SuRE) Award (R16).
Date: March 11–12, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
VerDate Sep<11>2014
23:58 Dec 27, 2024
Jkt 265001
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jason M. Chan, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, MSC 6200, Bethesda, Maryland
20892, 301–594–3663, jason.chan2@nih.gov.
Name of Committee: National Institute of
General Medical Sciences, Special Emphasis
Panel; Review of UE5 applications.
Date: March 18, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: Lee Warren Slice, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN12, Bethesda,
Maryland 20892, 301–435–0807, slicelw@
mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences, Special Emphasis
Panel; Review of SuRE and SuRE-First
applications.
Date: March 24–25, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: John J. Laffan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3AN18J, Bethesda, Maryland 20892, 301–
594–2773, laffanjo@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: December 20, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–31148 Filed 12–27–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Board
on Medical Rehabilitation Research.
PO 00000
Frm 00135
Fmt 4703
Sfmt 4703
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://
videocast.nih.gov/.
Name of Committee: National Advisory
Board on Medical Rehabilitation Research.
Date: May 5–6, 2025.
Time: May 05, 2025, 10:00 a.m. to 5:00
p.m.
Agenda: NICHD Director’s Report, NCMRR
Director’s Report, Scientific Research
Updates.
Address: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, 6710 B Rockledge Drive,
Bethesda, MD 20817.
Meeting Format: In Person and Virtual
Meeting.
Time: May 06, 2025, 10:00 a.m. to 5:00
p.m.
Agenda: NIH Rehabilitation Research
Conference Follow-up and Other Relevant
Policy and Research Issues.
Address: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, 6710 B Rockledge Drive,
Bethesda, MD 20817.
Meeting Format: In Person and Virtual
Meeting.
Contact Person: Ralph M. Nitkin, Ph.D.,
Deputy Director, National Center for Medical
Rehabilitation, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6710B Rockledge
Drive, Room 2116, Bethesda, MD 20892–
7510, (301) 402–4206, nitkinr@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Persons listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of an organization may
submit a letter of intent, a brief description
of the organization represented and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and
presentations may be limited to five minutes.
Both printed and electronic copies are
requested for the record. In addition, any
interested person may file written comments
with the committee by forwarding the
statement to the Contact Person listed on this
notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/about-
E:\FR\FM\30DEN1.SGM
30DEN1
]]>Agencies
[Federal Register Volume 89, Number 249 (Monday, December 30, 2024)]
[Notices]
[Pages 106539-106540]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-31148]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Initial Review Group Training and Workforce Development
Study Section--C Training & Workforce Development Study Section C
(TWD-C) Review of applications for the B2B & IRACDA Programs and
Scientific Meetings & Conferences.
Date: February 20-21, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, National Institute of
General Medical Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: Sonia Ivette Ortiz-Miranda, Ph.D., Scientific
Review Officer,
[[Page 106540]]
Scientific Review Branch, National Institute of General Medical
Sciences, National Institutes of Health, 45 Center Drive, MSC 6200,
Bethesda, Maryland 20892, 301-402-9448, [email protected].
Name of Committee: National Institute of General Medical
Sciences, Initial Review Group Training and Workforce Development
Study Section--B.
Date: February 24-25, 2025.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, National Institute of
General Medical Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: Latarsha J. Carithers, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, 45 Center Drive,
Room 3AN12C, Bethesda, Maryland 20892, 301-594-4859,
[email protected].
Name of Committee: National Institute of General Medical
Sciences Initial Review Group Training and Workforce Development
Study Section--A.
Date: March 6-7, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, National Institute of
General Medical Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: Adam Lawrence Heuberger, Ph.D., Scientific
Review Officer, Office of Scientific Review, National Institute of
General Medical Sciences, National Institutes of Health, 45 Center
Drive, MSC 6200, Bethesda, Maryland 20892, 301-480-4151,
[email protected].
Name of Committee: National Institute of General Medical
Sciences, Special Emphasis Panel; Review of ARC F99 and Mosaic K99
applications.
Date: March 11-12, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, National Institute of
General Medical Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: Lee Warren Slice, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, 45 Center Drive,
Room 3AN12, Bethesda, Maryland 20892, 301-435-0807,
[email protected].
Name of Committee: National Institute of General Medical
Sciences, Special Emphasis Panel; Review of Support for Research
Excellence (SuRE) Award (R16).
Date: March 11-12, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
General Medical Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jason M. Chan, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute of General Medical
Sciences, National Institutes of Health, 45 Center Drive, MSC 6200,
Bethesda, Maryland 20892, 301-594-3663, [email protected].
Name of Committee: National Institute of General Medical
Sciences, Special Emphasis Panel; Review of UE5 applications.
Date: March 18, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, National Institute of
General Medical Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: Lee Warren Slice, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, 45 Center Drive,
Room 3AN12, Bethesda, Maryland 20892, 301-435-0807,
[email protected].
Name of Committee: National Institute of General Medical
Sciences, Special Emphasis Panel; Review of SuRE and SuRE-First
applications.
Date: March 24-25, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
General Medical Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: John J. Laffan, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, Natcher Building,
45 Center Drive, Room 3AN18J, Bethesda, Maryland 20892, 301-594-
2773, [email protected].
(Catalogue of Federal Domestic Assistance Program No. 93.859,
Biomedical Research and Research Training, National Institutes of
Health, HHS)
Dated: December 20, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-31148 Filed 12-27-24; 8:45 am]
BILLING CODE 4140-01-P
